‘Must I take all my antibiotics?’ Why infectious disease experts are rethinking this longstanding rule
For decades, patients have been told to finish their antibiotics to prevent resistance, but emerging research challenges this dogma. Infectious disease experts now argue that the traditional advice is rooted in a misunderstanding of microbial resistance and may do more harm than good by unnecessarily disrupting the body’s microbiome. As clinical trials reshape prescribing practices, the shift toward shorter courses raises critical questions about how to balance efficacy, safety, and public health in antibiotic use.
What misconception underpins the longstanding advice to finish a full course of antibiotics?
The belief that stopping antibiotics early allows surviving bacteria to develop resistance is a misconception. In reality, resistance is more likely driven by prolonged antibiotic exposure itself, which disrupts the microbiome and gives resistant bacteria a survival advantage. Relapses, such as in strep throat, are often due to reinfection or inadequate drug penetration—not resistant bacteria.
How are clinicians adapting their antibiotic prescribing practices in light of new evidence?
Doctors are increasingly prescribing shorter courses of antibiotics, with typical durations shrinking from 14 days to 3, 5, or 7 days for many infections. This shift is based on clinical trials showing that shorter courses can be just as effective while reducing side effects and microbiome disruption. However, some infections still require longer treatment, and clinicians must tailor prescriptions to individual cases.
Why is using symptom improvement as a guide to stop antibiotics problematic?
While the idea of stopping antibiotics when symptoms improve is appealing, it lacks robust evidence. For some infections, patients may feel better but still require additional treatment to fully clear the infection and prevent recurrence. Additionally, symptom improvement is subjective, making it an unreliable metric for determining when to halt treatment.
What broader issue contributes more to antibiotic resistance than incomplete courses?
The overprescription of antibiotics for viral infections—such as colds or sinus infections—is a major driver of resistance. Roughly a third of global antibiotic prescriptions are inappropriate, often because patients demand treatment for conditions that do not respond to antibiotics. This misuse creates selective pressure for resistant bacteria to emerge.
Ce que ça pourrait changer
The reassessment of antibiotic duration could reduce unnecessary exposure to these drugs, thereby preserving their effectiveness while minimizing disruptions to the microbiome. However, the shift requires careful communication to avoid eroding public trust in medical advice, especially as misinformation about resistance already complicates public health efforts. Clinicians will need to rely more on evidence-based guidelines and patient education to ensure antibiotics are used judiciously.
